Поражение коронарных артерий у пациентов с аневризмой инфраренального отдела брюшной аорты

Авторы: В. С. Аракелян * - 1, А. К. Жане - 2

Организация:
1 - ФГБУ «Научный центр сердечно-сосудистой хирургии им. А. Н. Бакулева» (директор – академик РАН Л. А. Бокерия), Москва;
2 - Современный медицинский центр им. Х. М. Совмена – Клиника XXI века (ген. директор – А. К. Жане), Адыгея

Для корреспонденции: Сведения доступны для зарегистрированных пользователей.

Тип статьи: Кардиоангиология

Ключевые слова: аневризма брюшной аорты, ишемическая болезнь сердца, коронарные артерии

Полнотекстовая версия:  

 

Аннотация

В статье рассматриваются эпидемиология, этиология, факторы риска развития аневризмы брюшной аорты с сочетанными поражениями коронарных артерий, тактика и результаты лечения таких пациентов. Приводится обзор литературы как по основным факторам риска (гиперлипидемия, гипертензия, курение, сахарный диабет и др.), так и в зависимости от пола, возраста, генетических факторов. Подробно представлена тактика медикаментозного и хирургического лечения в совокупности с каждым из приведенных выше факторов. Особое внимание уделено стратегии профилактики, с учетом правильного образа жизни и применяемой медикаментозной терапии. В аспекте лекарственной терапии подробно рассматривается эффективность применения всех основных групп препаратов: бета- адреноблокаторов, статинов, ингибиторов АПФ, дезагрегантов. Послеоперационные результаты проанализированы в прямой зависимости от выраженности сопутствующей ишемической болезни сердца. В работе приведены данные литературы в отношении перспективы развития проблемы.

Литература

1. Alcorn H. G., Wolfson S. K. Jr, Sutton-Tyrrell K. et al. Risk factors for abdominal aortic aneurysms in older adults enrolled in The Cardiovascular Health Study // Arterioscler. Thromb. Vasc. Biol. 1996. Vol. l6. P. 963–970.

2. Back M. R., Leo F., Cuthbertson D. et al. Long-term survival after vascular surgery: Specific influence of cardiac factors and implications for preoperative evaluation // J. Vasc. Surg. 2004. Vol. 40. P. 752–760.

3. Barba A., Estallo L., Rodriguez L. et al. Detection of abdominal aortic aneurysm in patients with peripheral artery disease // Eur. J. Vasc. Endovasc. Surg. 2005. Vol. 30. P. 504–508.

4. Baumgartner I., Hirsch A. T., Abola M. T. et al. for the REACH Registry investigators. Cardiovascular risk profile and outcome of patients with abdominal aortic aneurysm in out-patients with atherothrombosis: Data from the Reduction of Atherothrombosis for Continued Health (REACH) Registry // J. Vasc. Surg. 2008. Vol. 48. P. 808–814.

5. Bayazit M., Gol M. K., Battaloglu B. et al. Routine coronary arteriography before abdominal aortic aneurysm repair // Am. J. Surg. 1995. Vol. 170. P. 246–250.

6. Bhatt D. L., Steg P. G., Ohman E. M. et al. for the REACH Registry investigators. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis // JAMA. 2006. Vol. 295. P. 180–189.

7. Boucher P., Gotthardt M., Li W. P. et al. LRP: Role in vascular wall integrity and protection from atherosclerosis // Science. 2003. Vol. 300. P. 329–332.

8. Clifton M. A. Familial abdominal aortic aneurysms // Br. J. Surg. 1977. Vol. 64. P. 765–766.

9. Cornuz J., Sidoti Pinto C., Tevaearai H., Egger M. Risk factors for asymptomatic abdominal aortic aneurysm: Systematic review and meta-analysis of population-based screening studies // Eur. J. Public. Health. 2004. Vol. l4. P. 343–349.

10. Crawford E. S., Saleh S. A., Babb J. W. 3rd et al. Infrarenal abdominal aortic aneurysm: Factors influencing survival after operation performed over a 25-year period // Ann. Surg. 1981. Vol. 193. P. 699–709.

11. Fleisher L. A., Beckman J. A., Brown K. A. et al.; ACC/AHA TASK FORCE MEMBERS, Smith S. C. Jr, Jacobs A. K., Adams C. D., Anderson J. L., Antman E. M. et al. ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): Developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery // Circulation. 2007. Vol. 116. P. 1971–1996.

12. Golledge J., Muller J., Daugherty A., Norman P. Abdominal aortic aneurysm: Рathogenesis and implications for management // Arterioscler. Thromb. Vasc. Biol. 2006. Vol. 26. P. 2605–2613.

13. Hattersley A. T., McCarthy M. I. What makes a good genetic association study? // Lancet. 2005. Vol. 366. P. 1315–1323.

14. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial // Lancet. 2002. Vol. 360. P. 7–22.

15. Hertzer N. R., Beven E. G., Young J. R. et al. Coronary artery disease in peripheral vascular patients. A classification of 1000 coronary angiograms and results of surgical management // Ann. Surg. 1984. Vol. 199. P. 223–233.

16. Islamoglu F., Atay Y., Can L. et al. Diagnosis and treatment of concomitant aortic and coronary disease: A retrospective study and brief review // Tex. Heart Inst. J. 1999. Vol. 26. P. 182–188.

17. Kieffer E., Chiche L., Baron J. F. et al. Coronary and carotid artery disease in patients with degenerative aneurysm of the descending thoracic or thoracoabdominal aorta: prevalence and impact on operative mortality // Ann. Vasc. Surg. 2002. Vol. 16. P. 79–84.

18. Kioka Y., Tanabe A., Kotani Y. et al. Review of coronary artery disease in patients with infrarenal abdominal aortic aneurysm // Circ. J. 2002. Vol. 66. P. 1110–1112.

19. Kishi K., Ito S., Hiasa Y. Risk factors and incidence of coronary artery lesions in patients with abdominal aortic aneurysms // Intern. Med. 1997. Vol. 36. P. 384–388.

20. Kuivaniemi H., Shibamura H., Arthur C. et al. Familial abdominal aortic aneurysms: Collection of 233 multiplex families // J. Vasc. Surg. 2003. Vol. 37. P. 340–345.

21. Landesberg G., Berlatzky Y., Bocher M. et al. A clinical survival score predicts the likelihood to benefit from preoperative thallium scanning and coronary revascularization before major vascular surgery // Eur. Heart J. 2007. Vol. 28. P. 533–539.

22. Lanne T., Sonesson B., Bergqvist D. et al. Diameter and compliance in the male human abdominal aorta: influence of age and aortic aneurysm // Eur. J. Vasc. Surg. 1992. Vol. 6. P. 178–184.

23. Lederle F. A., Johnson G. R., Wilson S. E. et al. Prevalence and associations of abdominal aortic aneurysm detected through screening. Aneurysm Detection and Management (ADAM) Veterans Affairs Cooperative Study Group // Ann. Intern. Med. 1997. Vol. 126. P. 441–449.

24. Lederle F. A., Johnson G. R., Wilson S. E. et al. The aneurysm detection and management study screening program: Validation cohort and final results. Aneurysm Detection and Management Veterans Affairs Cooperative Study Investigators // Arch. Intern. Med. 2000. Vol. l60. P. l425–1430.

25. Lederle F. A., Wilson S. E., Johnson G. R. et al. Aneurysm Detection and Management Veterans Affairs Cooperative Study Group. Immediate repair compared with surveillance of small abdominal aortic aneurysms // N. Engl. J. Med. 2002. Vol. 346. P. 1437–1444.

26. MacSweeney S. T., Young G., Greenhalgh R. M., Powell J. T. Mechanical properties of the aneurysmal aorta // Br. J. Surg. 1992. Vol. 79. P. 1281–1284.

27. McCormick M. L., Gavrila D., Weintraub N. L. Role of oxidative stress in the pathogenesis of abdominal aortic aneurysms // Arterioscler. Thromb. Vasc. Biol. 2007. Vol. 27. P. 46l–469.

28. McFalls E. O., Ward H. B., Moritz Т. Е. et al. Coronary-artery revascularization before elective major vascular surgery // N. Engl. J. Med. 2004. Vol. 351. P. 2795–2804.

29. Naydeck B. L., Sutton-Tyrrell K., Schiller K. D. et al. Prevalence and risk factors for abdominal aortic aneurysms in older adults with and without isolated systolic hypertension // Am. J. Cardiol. 1999. Vol. 83. P. 759–764.

30. Patrono С. Aspirin as an antiplatelet drug // N. Engl. J. Med. 1994. Vol. 330. P. 1287–1294.

31. Pleumeekers H. J., Hoes A. W., van der Does E. et al. Aneurysms of the abdominal aorta in older adults. The Rotterdam Study // Am. J. Epidemiol. 1995. Vol. l42. P. 1291–1299.

32. POISE Study Group, Devereaux P. J., Yang H., Yusuf S. et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): A randomised controlled trial // Lancet. 2008. Vol. 371. P. 1839–1847.

33. Poldermans D., Boersma E., Bax J. J. et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group // N. Engl. J. Med. 1999. Vol. 34l. P. 1789–1794.

34. Powell J. T., Greenhalgh R. M. Clinical practice. Small abdominal aortic aneurysms // N. Engl. J. Med. 2003. Vol. 348. P. 1895–1901.

35. Propranolol Aneurysm Trial Investigators. Propranolol for small abdominal aortic aneurysms: Results of a randomized trial // J. Vasc. Surg. 2002. Vol. 35. P. 72–79.

36. Reed D., Reed C., Stemmermann G., Hayashi T. Are aortic aneurysms caused by atherosclerosis? // Circulation. 1992. Vol. 85. P. 205–H.

37. Schouten O., Bax J. J., Dunkelgrun M. et al. Statins for the prevention of perioperative cardiovascular complications in vascular surgery // J. Vasc. Surg. 2006. Vol. 44. P. 4l9–424.

38. Sever P. New hypertension guidelines from the National Institute for Health and Clinical Excellence and the British Hypertension Society // J. Renin Angiotensin Aldosterone Syst. 2006. Vol. 7. P. 61–63.

39. Simoni G., Pastorino C., Perrone R. et al. Screening for abdominal aortic aneurysms and associated risk factors in a general population // Eur. J. Vasc. Endovasc. Surg. 1995. Vol. 10. P. 207–210.

40. Singh K., Bonaa K. H., Jacobsen B. K. et al. Prevalence of and risk factors for abdominal aortic aneurysms in a population-based study: The Tromso Study // Am. J. Epidemiol. 2001. Vol. 154. P. 236–244.

41. Sukhija R., Aronow W. S., Yalamanchili K. et al. Prevalence of coronary artery disease, lower extremity peripheral arterial disease, and cerebrovascular disease in 110 men with an abdominal aortic aneurysm // Am. J. Cardiol. 2004. Vol. 94. P. 1358–1359.

42. Takahashi J., Okude J., Gohda T. et al. Coronary artery bypass surgery in patients with abdominal aortic aneurysm: Detection and treatment of concomitant coronary artery disease // Ann. Thorac. Cardiovasc. Surg. 2002. Vol. 8. P. 213–219.

43. The Joint British Societies' (JBS 2) guidelines on prevention of cardiovascular disease in clinical practice // Heart. 2005. Vol. 91 (Suppl. 5). P. 5l–52.

44. Thompson R. W., Geraghty P. J., Lee J. K. Abdominal aortic aneurysms: Basic mechanisms and clinical implications // Curr. Probl. Surg. 2002. Vol. 39. P. 110–230.

45. Tilson M. D. Aortic aneurysms and atherosclerosis // Circulation. 1992. Vol. 85. P. 378–379.

46. Vammen S., Lindholt J. S., Ostergaard L. et al. Randomized double-blind controlled trial of roxithromycin for prevention of abdominal aortic aneurysm expansion // Br. J. Surg. 2001. Vol. 88. P. 1066–1072.

47. Van Kuijk J. P., Flu W. J., Dunckelgrun M. et al. Coronary artery disease in patients with abdominal aortic aneurysm: A review article // J. Cardiovasc. Surg. (Torino). 2009. Vol. 50, № 1. P. 93–107.

48. Vulin A. L., Stanley F. M. Oxidative stress activates the plasminogen activator inhibitor type 1 (PAI-1) promoter through an AP-1 response element and cooperates with insulin for additive effects on PAI-1 transcription // J. Biol. Chem. 2004. Vol. 279. P. 25172–25178.

49. Walker S. R., Macierewicz J., MacSweeney S. T. et al. Mortality rates following endovascular repair of abdominal aortic aneurysms // J. Endovasc. Surg. 1999. Vol. 6. P. 233–238.

Электронная подписка

Для получения доступа к тексту статей журнала воспользуйтесь услугой «Электронная подписка»:

Оформить подписку Подробнее об электронной подписке

Главный редактор

Лео Антонович Бокерия, академик РАН и РАМН

Лео Антонович Бокерия, доктор медицинских наук, профессор, академик РАН и РАМН, директор


 Если вы заметили опечатку, выделите текст и нажмите alt+A